- Home
- ISTR vs CRVO Comparison
ISTR vs CRVO Comparison
Compare ISTR & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ISTR | CRVO |
|---|---|---|
| Founded | 2006 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.3M | 89.1M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | ISTR | CRVO |
|---|---|---|
| Price | $27.20 | $8.37 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $29.00 | $21.50 |
| AVG Volume (30 Days) | 34.5K | ★ 79.7K |
| Earning Date | 01-22-2026 | 11-10-2025 |
| Dividend Yield | ★ 1.62% | N/A |
| EPS Growth | ★ 24.14 | N/A |
| EPS | ★ 2.22 | N/A |
| Revenue | ★ $93,426,000.00 | $6,159,786.00 |
| Revenue This Year | $7.24 | N/A |
| Revenue Next Year | $70.19 | N/A |
| P/E Ratio | $12.23 | ★ N/A |
| Revenue Growth | ★ 12.93 | N/A |
| 52 Week Low | $15.39 | $1.80 |
| 52 Week High | $27.42 | $16.94 |
Technical Indicators
Market Signals| Indicator | ISTR | CRVO |
|---|---|---|
| Relative Strength Index (RSI) | 81.59 | 48.39 |
| Support Level | $26.04 | $8.13 |
| Resistance Level | $27.42 | $9.22 |
| Average True Range (ATR) | 0.51 | 0.61 |
| MACD | 0.20 | -0.12 |
| Stochastic Oscillator | 94.10 | 23.41 |
Price Performance
Historical ComparisonAbout ISTR Investar Holding Corporation
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.